                 ABSTPACTO  Cr@' !'=-SUI@T.'.@
                            Sinep. St@irt of               T@.t3  porffbn of thz suf-.,-..ary
                               p                                    Du
                 covers   the''ertod   '('r-am t  July 1",;PSIo       -cz,,nber 1'-'4.  As
                 stated   -,bove                                              T
                                  the' obj,,@-etive of the   projcct  Is to
                 synthcfic   drug wol4tch would be as affecolive aact as sat'c from
                 the points   of vic,,j of human foxicify and a,-.'diction  liability
              2   as Is eodeinz.  Althouch adequate synthetic substi@,utes for
                 morp,%Ine arc available.,, such a sulistance is nectlcd becauzz
                 no such dru3 of the codeinc-type Is knok-;n.           S c,.,e n t y.
                 per cent of the needs for narcotics are for codclne rafher
              2   than mor,-)hlnz.   T.@is r..-,cans fhaf the  Unite--I Stziil,--s musil
                 co,-ifir.u'-. to       and stockpile opium unfllt an ideclu,:! 14 u-
                 pynl
                    ih-.tic stibstifu-@l-. -for cod@in.- has beca                   '2She
                 role or' tNe         Addi'c-flon Re3oarch Czn#ler  In thi-, tnvesill-
                 ,gati3r, concl.@t,., of,thz cycslcr.-,nl.na't ton o-il tl-.c ad,-jilctive
                 propertics cf n--w druos.  Ti2ia e-iatuaflon of tFe anai.,7ealc
                 and anfitussiv-- effects r-.-ist neccssarlty be made elsev.@cre.
                      The r-.c@hods u.,,cd for              t!ie addiction  flabillif-Is
                 of new anatc@--stcs 4aiz bc,-@n  dzscr2ibz-3  In  de-t@all  i.,i  tiiz
                 pr.oj,,c@ dezcrii-ii-.ins and  in  @,r::@vious  procrzss  rep,.-r4's.   ue- s
                 to be ctudil-d as synfhetic                     f@,-r  co-4clnz  are
                                      C:r
     2            r @, Iz
                                                       c s
                 and t'arcoi ic; olf           Iona I     -zarch Couacil.         ri u- h
                 dr-jos a rz r e cc i@v-- d a t t li,-, 1-,l Add I c t I.-o n R z s @- a r ch r. f e r
                 lhc hu.-,an                 of f,%c cor-.p,),jiids  Is         L-,y
                 detc,,-rifnir.,,            varlot-,s eoses o,,i blood

                        rcspiratory         minuile    vatur,,es    body    te.-.iperaturc,,    pupl    I     lcr,/
                        eizz,               Folio-ting coriipi.eflon of  t'lle  basic  pharmacc-
                        logit-al  viork,  c-11'1'ects  of  the  drugs  on  thf.,  behav'tor  OT
                                                   addtcfs       are       evatuatcd       by        &drlintstering
                                'fr.  d'ses  based on  flic  results  obtained/fhe  pharr@aco-
                        t@en            0
                        toeical  exocrlr-.ents.    IT'.thc  drug  2Induces  bei@aviorat  effects
                        reseriblina  those  seen  after  administration of morphine  or
                                                                                                                             t
                        codefiicj,  It  Is  very  likely  to  possessaddiction  flablitty.
                        The  ability    2    of  the  drug  to  reltev,-  or  to  prcvenf  the
                        a,.,)peerance    of    Syr.-pt'oms  of abstincnce            from morphine  ts  next
                        .,@tidled      In p-tic-':  stro.-i'gly         addictcd      @to morolitne.           If  f.@z
                   2     erus        under 'test  relieves  or  suppresses  abstinencer  tt  is
                                   'fo  havc a--'dicil     to.-i  ttabl'sity.         In  su-h
                        the  datc  of       the  drun...'ur,,-,;er  tesf  which        Is  required  'i-o  retlevc
                        or  su-2prcss        41!1.z               of  ab'stlnc,-ice  anc.?  t,%c  dec,-i-ee  oT
                                  ,)r-suopresston  of  abstinence  are  Indices  for  ccr.-,oari3on
                                             -la  rd drug,  codzine.
                        %7 li
                               .,hen  an     cspcc2lail,/ promisin@i  drug  becories  evallabic,
                              s     j   I -z d-  b -/  f!i --  d I r c c S4  a dI c t I o n  t c c h n I cThts  Involves
                                     i  z   r z: t I    f  a s c - n cl. I i do @., c s  t o o r n-- r   d. d I c t
                                      s  a    r  2p -z r o      o       -le  r a ri  I n g  b c    c n  30  to  l'OO
                                                                                     ull                                ar-
                          y:;
                                  D     r                                r                          r..ieasurer:.e.
                        carried  oul-  to       dc-ecs'  and ey-aluate            the  developme,-.f  of  folera  c,.
                                                                       a b r uo    y    a      0 b 3              3  f 0 r
                        r
                                        rj - s  ar,    e, I 'T;, ei r a
                             d - ve     p,-ne r.   o   a b    I n n c c  s @Tip t oris  -2-,a c4z
                                                              'uring           period    I    July     I'Si     f-o
                              T,:c
                                 Dc-ember          ar-  febutaied         belo-.t:
                                                                                                                         , gt

                                                                                                                                               
I.fT  IL  IT  Y
                                                                   Ar)D, ICT ION  L IAD I L ll'Y                       ToX IC ITY              
(,71)ss IB LE
                         OP LJ3                                   (Relative  to  Coe-cint7)   (Relative  4-0
                                                                                                                                               
fie
       L,,--orphAn                                                      Mucfi  flighe.@                            Greater
       t  --rjrrimt)ran
                               r  of  Le2vorphan                         Higher                                     Greater                    
I-F                  i7ould  be
                       ethl
                                                                                                                                               
LI:3 ed  f or  ri I I (I  pa I it
             ti)ylmcftiylatiilno-I2 -1   (2t                                                                        Higher                     
n
       ,ji  iii   len-li   But-i-ene
                                      il   121                          Higher                                     Greater                     
l') n c
             It I c n v I  6 u t - I - e n e
                                           2                             Lower                                      L6 we VI
          .-'L-Ir or,.o r a n
                                        (3-Mctlivl                      tower                                      Lo tic r                    
V-@ r v  I)i- (i-,i I s i.-)g f o r
                                                                                                                 2                             
C   u,-i It
       cl@t-ir  of  D,.-xi-ro,)Iian)
                                                                                                                                               
I b I  Iii-les
                                           dimethyl-                    lilutier                                   Soev2illat   less
                                                                                                                                               
r,)r       paln        i-elicf
       ttinoethyl                   Voicrate
                                                                                                                                               
SI  ICIlit        Pf)$Sll-.)Il I I- I
       (i    2:2-t)t  fienyt-4           dime.thyl-                     Hictier                                    About  equal
         ..,Inoctliy                Valerate                                                                                                   
f,-)r.paiii             relief
       I  6-2.2.i.Dtpticnyl-4  climcfhvi-                                                                           %Some v.,'Il 8 I. less     
Slight              P-.)Sslbil I t I c s
       a,-.        lnoethyl        Voler@.te                                                                                                   
for        p2ain         relief
                                                                                                                                               
Slight             r)c.,sslbll ltics
             ethyl  2-,,....Dtphcnyl-4.                                 Higher                                     So ml- tvb a t    leis
                                                                        7                                                                      
f @)r   pat         c I IC @c'
       '9"1'f-.,.cthylamlno  butyrate                                                                                                          
n  r

                                                                                             -OX IC ITY
                                                                    -L !AB I L ITY                                      oss I B LI'
                  DR,LJ13                            ADL) ICT ICN                                                                c  VCILITY
                                                  (Relafiv2c  to Coclelne)            (Rcl@tlve  to C(3detn'c.)
         I pli aI -hie t li a do I                      Higher
                                                                                        Higher                          1,,-) n c
          t a -d I -NIIC t h ado I
                                                        Higher                           Loiver 2                      Lln 1. no v@n
              rl-Dimcft)YI"3-ltydroxy-                 Higher                            Less
      :',rpli Ina n                                                                                                   LItiLnovin
                                                                                        Some Villa t
                  2                                                                                        11 C
                                                                                                             r        Possll>lc  for relief
        trobinan':@
                                                                                                                      of pa In
      '@ixturcs  (1-10,  I-Sp  1-3)
      i  2                                                                               About  equal                  V c-- r v  I lri I IL c
cl
          I-,'%Jlorpitlne and 1,,'orphlne"."-.                                                                        P,)Sslbillfies
      A
       @-4-Diphenyl     -d Ime t b VI am lno--         Higher                           Sofne tvh a t. ti Ili C r     @'(,.ry dcf In I  te
            none-3                                                                                                    P,-) 8
                                                                                                                          slbillti;      s f  r
                                                   2                                                                   cour
                                                                                                                              ,n ri Pa..
nrelief
  %VIA r!.  not onfiretv     completed during          period               to  I.I...cy4
        L;-Iow for further detalls;@l

                                                          Cb         0                                                                         
co
                                                                                                                                               
C:;
                                                                                       2                                                       
C                    -O        fq                                                                             <
                                                C'@                                                                                            
2   CL
                                                                                                                                               
11        ii                                                               -to
                                                C4        n                                                      a                             
fn                        -t-           2                   Z        40
                                                                                                                 -t-                           
-4-0                                                                           %*     -1
                                                          ri                                                                          to       
0          tv                                   2                   'k)                                                                        
cr
                                                                                                                                               
CL     A
                                                0                                                                              2               
0  '   il@L
                                                                                                                                               
r        a,  .                         -          4q
                                                               2                                                                               
CL        0                                                      C&             0
                                                                                                                                               
0
                                                                     2                                                                         
cr
                                                                                                                                               
0              'O       0
                                                0                                                                                              
\r-                  cr                   0                         CL                                                           C             
0
                                                i,@       =r                                                     J                             
W.)                  44        0           2                                :r         C%                                                    CL
'U
                                                a         to         -tl                   C4                    .14                           
-41                                                                        a                         0        0
                                                CL
                       2                                              0                     cii                                        ei      
X          :3
                                                                                                                                               
Z141
               2                                           O-                    C          Lr                                                 
:3         c@o
                                                          11                                                               i3                  
2                         (L     X          --i
                                                $at       C                                                                           0        
n.                                             CL                               (a       40                 n
                                                                     0                                                                     2   
.,t.                                                    44          --O
                                                                     -1                              :a,                                       
n      0                                                     401
                                                                     0                   2                                                     
co                                                                                                                                          :7-
                                                                                                                                               
'U                          0
       2                                                                         'U                                                            
0                         0
                                                n                                                                                              
-0                   co
                                      2          o                                                                                             
ib                   <
                                                L).                                                                                            
zr        D                               :3                                                                                     cr
                       2                         (I        Cb                               CL                                                 
:3                              -I-                                                                 0       -3         ei       10
                                                                                           0         CL                               eq       
0          Lq                   'e)                                .0
                                                                                                                                               
..)     (4         -
                                                                                C.L
                                                                 2                          0         -r)                                      
0                               -4-                                                        7u
                                                                                           V4        41,@                                      
-          a         ,.,N                                                             :3,           2            C4       C:                   
C          7J
                                                                     'U                                                                        
0                                                               CL        (a
                                                                                                      2                                        
le
                                                                                           0                                                   
ico                                                                                                             -
                                                f         0                     C)         -1*                                                 
2cr         0                    :71       0                                           n          0              0                Gi
                                                                                                                                               
0          0                    C                                0
                                                                                                     r2it                              0       
CT                               3          (4                      -C
                                                                                                                                               
-          r$        -t.                                         70         -              -        op
                                  2                                              n                                                             
o         =rl                                                    -<             cn       40
                                                                                I'll       -t-                                                 
11        &                                                     2                C4
                                                                                -:.I       0                                                   
0              0        'O      0
                                                                                'U                                                             
20          C                                           W
                                                                                                                                               
0
                                                                                                     X                                         
2     cr     m                                                                         n
                                                                                ei,        :,J       Po                                        
.14                  0         n          -42           4A          ri     LI$        m              cr       at
                                                44-                    2                                                                       
-C        n                               0                         cr                m              m                                         
CL
                                                                                                                                               
0         11                   -r         11            -   2        -      n          O.             -1       -
                                                                     n                                                                C:       
Go                                                                                                              4A       1<      ::r        CL
                                                                                                                               2          Q    
-I-                                                                                              3a                                         C
                                                          ti         44                                                    44                  
0                                                                   n                                      C).     2   -i
                                                                                                                           Cb                  
0          O.                                        r.L           C4          0                                                 Go
                                                                                                                           .41                 
C).    2              tq                                          94
                                                                                                                                               
0
                                                                                                                                               
2                                                 O-
                                                                                                                                               
0                                             Cb
                                                                                                                                               
C                                             Ca
               7                                                                                                                               
0
                                                                                                                                               
(L                                 0

                                                  '7'iis              rcprczenf3       another
                                                                                                  possible
                                     for codeine since  tt  Is  In act!
                                                                                       ve.use I n G@e r,,na n y
                    as   a  cough  Sluppr4issanf-*        Ft.,rfhcrmore,  J*f shoijfd,      be a nild
                    an,519estc    cnd    I--     castl,/ a yqfhcz I zed.
                                               y
                                  .3.    Benz    I nio r,,-.)    yris4yl  cster.         This  drvg
 2                   which    %7as  dev-, topzd    tn Fratice,,  is  ..Insoluble  In water aind
                                               ly a
                    can be     Injected on           s oral'suspcnsion.   For  this  reason,
                                                       4
                    all  work carried out          with      the drug has been by the oral
     2               route.   Doses rangtng            up to 600 mg. orally did not  Induce any
                    def In ite  -mrph Ine-I lkc e-#:'fects        In -lonfoleratif addl@cfs.
                    Transient  skin       eruptions consisting of blote-hy erytheno and
                    urticartal  v.,hr-.ols wer-. obs      I-rved  In bo@h of  the patients
                    who reczlvcd                         dos           z  drug  was co.,.lotefcty
                    inzffective  In  SUOprZt.3ing absfinz@icc-  Tror". rior!,a!iina.                 'I e
                    dru-  Is  not rega.-d-@-d @-fts  a -romisl,,ig                       since     It  Is
                    not a  true  synthetic, has           too  hio.'t  foxicifvp  and  Is        probably
                    therapeufically  lnerfe
                                  4.    B c t    I     t h a @o I    In cicses  renoing bcfwccn 30
                    2to  100 ric,,. o,-all-,l f-,r subrt.,#'a;-.couslyp  beta-di-r,-.cfha-Jol  did not
                    It                                                                         of a',.-s'rirc,-icc
                    froin,rr;orp,%'inc  In    f  -o r. I i a .1   1 2d         n         If  Is,
                    j U,:@,,- a C,o      n   a
                    clinical    c!afa    avallablz    on    lh-, poss-i'clc    -talue of'   be'la-di-
                         a      a s a P. a a  14 u s I  c         a       IC     -a -I                           s
                                'el IC
4                    as a  syn.-it

                                present                     T h I s dr             0   hovic Y;z r j,   c a s   I y  c   -n,  Ica I
                          ce.,i vc r..t I b I cto                                                 a   drug  with  ver,/  hi-.@
                          adctlcf ton        lab I I I t          For              rcasi.->n,  It       Is  u.,2rllkcly  ihof
                          It  would  be        reeard4d  as  belng  a  safe  substitute  for  codoin-..
                                           5      Addiction  liability  of  Natorphine-i@.orohinz
                          II-IOI     Llixture.           In  previous                          If  %,ias  sho-xn  that 2 mixturzs
                                alorphine  and  tr  rphine  vere  not  likely  to  be  abused  b,/
                          of    N                             0
                          drug  addicts  sin                 'm
                                                      cc      O.-Ph It-ie-induted            -u:.Dhorta  to  effcctlvely
                          blocked  for          2   hour:  by  the  Natorphine  and  since  T.njcctloa  cf
                          such  a  mixture -xvould  precipif ate  abst inence   In  add lcted
                          Individuals.    Pr--vious  direct  acldiction  experiment's  @,vith  fhls
                                                I ,  d 'administration  o;2  very  fil,.gh  do=,3.  ('*addicting
                          mixture  tnvo  Ve
                          dose  sche4@uic').              N@o  ln--'I@orr.,aflon  was  available  on
                          of 'AL '.-Acrapeutic         doses        chron Ica I I v.   :Fo r  th I s  re&-i-ciT,  (5  poll lenf 3
                                              I 0
                          warc     C'i                     -or, line                     r@-0.  tlalorp'iire  ever                'our
                                                                                                                              y
                          hours  f or  '50, -da ys.,  ,f ter  rih ic-h  t'ac  0',-ug' -.ia s  w I itidr,*wn                        't"he
                          ur,pleasenf         side  er-fec@s  no,4cd  with    addic'&-ing"  3c'.,,idu'les  eid
                          r.of  a.@>p-ar                                                    c!.-ise  scil,@duic.          Dlfinlte.,
                          mi,id  absfi,-LC.'ICC,                           appecred         folio-aing
                                 ml-turc)                                                          a-#  s,  pic-i-A  Olt'  zi 'D
                                                                                                       2..i I n I s f r:--t
                          fai                                                                                                         10
                          c     r    f o -,j r  o u,- s  T- o r        C' zi a  '&- o  t                                          li c r c
                                                                                                        t   c  2      'T j r c  I s  al
                                                                                              y  or
                          In   one   sens.3   the   ad-,Al   1   c   f    Io   .1 I-ab II  I
                                     ,s                                        =or                             ase.
                                o r ;>h I n        roh  I  -  -     x     vr    is  ra0@hcr                                       1%@y

                          Is   not             rcoardec!        a  pro.-.iisino  Su-bsfitutc                   for     coecine.
                          Fvrther,mre@,               if           not  a   t r tic  t yn     h c i- Tc
                                             6.      klorph        inc  Antagon?3t3            Cther            than             @@.alorohine.
                                   Is  beirg-uneertakcn   In  the  hope  of  developing  a  r,)or,,-.>ht:ilz
                          anta!gontst         v.,bich         Is         orally         effzctlye.         The         coinbination         of
                          such       an       antagonist      2 tvlfh       a       svnthztlc        such        as        methadonep        or
                          Racemorp.@an,,  might  decrease  addiction   liability  and,,  f@-crefore,
                          be  regarded-as  a  po,sslblc  substitut'e  for  cocj'ctne.    @:7ork  wlih
                          four  stnthette  ant'agonistl.'  has  bcen                              partty  cor@-platedif
                                                       @@(a)          Levallorphan.          This          Is          the         
levorolatory
                          I,lo,-.ohina.,i  analocue  of  @4alorpi@lnc*                          The     dru-0      i%.as 2     bec,,i     
stiown
                          to      be      an       eflr'cc;fiva       antac,,Onlst       to       -io,rpht;-I.-.       and      
Racc,r-,irphanp
                          bo,th          subcutaneou:iy          an-.,          oralf,@a          The           antagoalstic           effects
                    2      persist   tonoer  ffian  d                    'thoze                                       S e r I a u-s-          I
c
                                                                    01
                                                                            .u
                          rcae-lillo#-#s  may  oect,,r' wif@@
                                                       2                                          of  nausco:  vo
                          pr4zcloij'ouS        dropt'        In        blood'p!rcsosure.        To@@-ic'        -,ff'-ts        of'        
4!le
                          cc,m.-pou,-id      In       dos,-$       whic,@                    u-slz,-J     In2     riixfures     ar,,,      n,)f
                          of                  IOU3  ccns,@qu-znc,@-.                 -1-Ince fhz  drug   Is  cf-k:'ec$'Ivz
                          c r a     i  i               r    cl c     n             s s 1 b             3     c r        c   c-le-i            
nf
               2                                                                  t   r z
                          OT
                                                                                       r o
                                                                     C
                          dcxf-rorof,3tory               i sor.,.er  o.@  Lava          lor.-,,ian         A
                                                       4                                                            linn  consti'4-ucnt
                            u             c r t                  e r c f   r c            n,:;    a     r o ,n
                                   n  a a f a

                                            t C     Le va                  an.     Th Is.  comonund      I s  tha
                     @3-n-@-thyl  ether of,      Lcvailorphan and was -4'ound              to be  effecflvzp
                     either    -@ralt@ or  subcufa,7covsly,  In anlagon:i-zing                   flic2- efr'z-- 'Jr- s
                     of    riorphine    or     Paceriorr,,,%ar,..     Untoytird     sldc     effects     appearad
                     vi ti'l  clo scs grca ter  t hcn  5            @@"*h I le a def I n I f e poss ib I I I t  y
                     as  a constttucnt  of an anfaC;onist2-anaIC3estc nixturej,  It
                     possesses     no      advanta-z.s      over      the      parent      compound,      Levallorphan.
                                            id)  -3-Hydroxy.-iN-Propargyl.tl4orphina4le                  This
                     c.or&.pound  Is of espectaf  Interest  since  It produces  analge2sic
                   -effects    In     mtce@@which     are     equal     to     those     induced     by     meparidine.
                     Despit.--  this,     the    eru-     Is     an     ef;lectlye     zatagonist     when
                     ad,-..Inlstered     si@bcutancousl,/,     but     13     far     IC$3      CfT'CCfIVC  WhCft
         2            administcrcd   orcllv.   :It   @,at    t,-en    shc-@,i,-i    to    precipil.*;,,-_--    sl-lptoris
                     of abst In en cc f ro,-.i r.,orprh in e  In a ad I           p&f 1-nt&              Ihcrefore
                     it is ro.4 11'4e!y f(@,,bc abLz@-,d,b.y                                     If    OT,fcrs     Some
                     promise  as  beir.- im  possib".c  subsfilute  for  codci,-)c  T',.)r  .he
                     relief. of M.I'id      palho
                                            I       1-3-Acc f                   I.,ior-norph ? na n
                     compound    is     also     an-cT"T'ecti-.,c     arsla--,cnts@     whcn     inj-zctcd
                     3 ubc uf a n--.Dus
                                                                                a.,,  an7aoon T:f -ani@ l@@es IC
              2                 a s p,-o.-i  s  nC4 a  cori      f Lt-n
                     m  X r            S
                                                                                                         ,cc-,! Ca  y
                                    7.   t,,r@rcotine.               co,,,Poundi,  fcov        no'T    C$'
                                      n-,ir5phlnzj  Is  deri@-,-j              ool,--m,  and  I,,)
                                         no';,' beco-c

                                                  I n        h@.man      and  animals.               If    f-h Is    Is     conf     1',-ricd,
                          the  drug  ml             Nt       a@  possible  substitute  for  codeine  as  an
                          ant-ifusstve           and  would,           thereforz..  have  the  ef-rec-f  of  ex.end?nC.
                          th-.  suppl,/.of  codeine  derived  from  opium.    In                                                 doses-ranging
                          up  to  100 mg.$  either  orally  or  su!:)cutancously,  t,%c  compoun,,,
                          does         hot         Induce         morphine-like         effects         In         nontoteranf          former
                         2 morphine        addicts.        @b         untoward         FOXIC         effects         i@iere         observl-.d.
                          It  appears  to  be  totaity  devoid  of  any  ability  to  suppress
                          synptoms  of  abstinence  from  morphine.    This  co..np'ound  Is,
                          therefore#  rega@2'rded  as  bzlrg  very  promis-ing.
                                             8.    Dlhydrohydrohydroxyri-orohinc.    Tt",I&  c;otrpo,w,nt
                          Is  the  morphin4  analogue  or'  eu'40'dal   t@,4,lhydrohydroxycoc!-.Inone).
                          In  dotes  of  22  to  3             rig,*'   subcutaneous I y,,             '.f   induces  rarlt;-.zd
                          r,,orphine-It@.,c  effects                   I nc I ud I        c upo-r-c r I a       It        rclicv.-s        anJ
                          Su,aprcsscs  astinence                    T'rc.:@i mor,-.2)htne  c-.m-)Icfely.                   lis
                          addicilic,i       ll,'abiltily       and       toxicity       are       far        greater        than        'Those
                          of  codeinone.    The  drug   Is,  therefore2  not  a  suitable
                          codeine  subsf ttulic.
         2                                                      V p b c n o n - c; A,   J    z 1,                       2     d
                          2-proplonoxy-3-rlct'-Ylbu'a:-,c                             T'.i t s  compounc.1  %vas-                    I y
                                                                                                           c.-i  and     2        t'arc.o.'Ics.
                                             by  fhc  Comniftce  o-                 C)rug  Adeic'i c
                                   @l i -7.,a        r -       'o       a n     o r c I $,-i i          c I 1 n    a
                                                     this      d. r t,.- -;a   yhave'anaf--!cslc  pro-erti@3
                          indicaf,-  f,@:3iL
                                                                                                                                         r   c 
r c
                          z-:)rox 1-@.a          Y   c,;ulvalcnl
                          a@    very    im:%,->rtant    c;lru!g     s     2ticc- t o  @4a f                     n     z,- 1-@ 7 ub s  I t  u  f
s

                    for        codetne hav--  bee n  a.-, t  us s        ra   he r  than       ano I oz's t c-5
                    So  f a r. o.,i  I pret  nfne-ry f,,-txlcol-,<itcal  Infc,-rmatlo,,).  is
                    avatiable'.       In doses      raii@;lnn  U,,)  to  250 riig.  oral    ty nc  evidence
                    of rrorphine-til-c effect
                                                       a  or ..-norphine-fi'<e  euphoria  have  b-zen
                    observed         In nonfolerarf  forriler morphine  acidicfs.               tb.serfous
                    toxic  effecfs  have        been  obse2rved.
                    S LLI@-A R Y. Of  the  compounds  studied  so  far.,  two                       are'rcgorded
                         xtrer.-elyoromising  as  antifussi
                    as  c                                               ve  agents.        These  comoovAd3
                    are  Dexfronethorphan  and t,!arcotine.   Citnlcal                   e va I  ua  f  ton  of:
                    the  antifussive-'propertles  of  both  are  curreritly  underway ar,-J
                    II'  seems  probable  that  both  compounds  will  soon  comc  into  the
                    ma r k c f e s  c o n  f u c n t s  or" 3 n   v s s i ve  m i x f u rs   Tiie&e  drugs,
                    howevcr,  co.-2ist I tute     an'  answc,-     o o n- I v-       f ;i a  p r o b 1,-: -n In
                    addition  to  its  use       as 'an  &!it  If u'ss ive --accnt,  cod-z inc  Is
                                                                                             o'
                    exfcnslvely used  fo@  fh-.:  r         I le'T'     r.1 1 1 d -z r  c, @- a d. aoa In.
                    As  yet  no  Otf.g  Is  available  which..         ls@  lc-,nown.@o  be  a  s       c t 1 v-,
                    as  Coe-,-Inz  for  this     purpose  aid               'las  c-s  to.-i addlclklon
                    !iabill@ry and as  low  to,-lic2iti/.
                    P
                          If-nmedtafe  Plan-a@o.     During           ccmin@,- si,.%- rionths iie  hoie
                                                                    c  c
                    TO pari4 I Y                                               tii  a      c -,I    c  i';
                                                 2                                                c,)
                            c       Y      C
                    These  compoun,4              r o PC x Y"a,% n'Ol c 1.'ice par     9               thr,,:e
                                      ,s are
                    r-,,- mbc r s o h a   ::a c c I     p 'T a i @z  s c r I c.sad  P     c ;d-i' i7.c. @-..a  1,.,.z

                      The:,,Azec-,ectoll,cptanes          arc  of  great  tnfcrest                   since  no        evid-.nce
                      of'   addict   toa,   I   iabl-l   It,/ -to    one     of these           corlpounds  was  defected
                      In  an  experiment           usini      r.-onkeys      at      the      U,,tlvcriitv2  of
                      Pre I Im I na,,,t. c     Inical      I n,Fo t-.-ia t to nhas  already  Indicated  fliaf
                      these  drugs  may be  effective  analgesics.                             lflt.@tt      Is       true,
                      a n d  I f  t,% c I r  a dd I c t I o n  I I a b I I I I,- y  I s lo -.v.,  a s  I n d I c a t z d  b v  t 2h z
                      expert,-nenfs  at  hilchic,,an.,  they ril-ht  be  effectively  substituted
                      f,ar  codeine        In  reitcvtnj  ial'lo             The        'drug        Plper@idir,,ef.@adon,,
                      is     also     already     in     clinical     us;e      In      Great     2 Britain          thercT'Oref
                      is  of  sorc  tnterest.                    al3c      hope      to      proceed      further      with
                            develool-ilent       of'        a,,i'@-agonist-analgcsic        ntxl&ures,        vith        chief
                      emphasis  on  Lev;bflorphan.                  Further  sl-u,,Iics  of  a-h"@ic;-rory-
                      N-Properqy                   in--l .-.. Id '-.rect                     are       also       Indic--fc,4,.
                              L,--n-,-renf7c  Plans:'                lntcnc?    to    cont    lnuc     ths     a,-2arch     @'or
                      ar,  a--4cq ua      s yn     c t @c   s ub s t I f         or  -dodcin--  until  a  drugs  or
                      druG.-,  Is  T'otwd  which            arr-      l.u.@-cd by  f@ic Co,,nmiffec  on  Drug
                                                                                                         2   @O
                      Ae,,-.4aiction  and infarco.       Ic-.@  of  th-@,.  t,.'af lo,-ia I  Rcscarch  '  ur-c II
                      Tvlfllt  al,l  the  neccq-sary requirzr,-.,znts.                       Cnl,/ susoenslon  oT'
                                                              2                       I      i Lt s  t;l a r k  t     a  s  7
                      prl--,r  to  the  ai-fain,-,znt  cf  thts
                         Iron>.-It                                 !r,)uri,--   currz,,if      re:) -or     o:criod)
                                                   H., and  Fr,@s..---r,       H - Ic 0       dcl I c  I        r
                                     of                     L'@erivat&lycs  tabsfrdct).                 Fcdcration

               r4EP02TS AINO P@MLt3NTICVS-*   (Coat td),
                     2.  Fraser, ti.F.s. rlash., T.'#-,,$ Van Horns G*D*., and
                          Isbell,, II.: Use of  &@,lotte Effects 1,.l E@valuatlr.,g
                          Aoalocslc Drugs In  @;',an.  Arch. lntcr2nat..dz
                          pharmatodyn. et de   therap.0 9f'io. (4) 443-45 (Aug.)
                          19540
                     3.   Reports to Co..-xilffee on Drug Addiction and t-4arcuffi.-si
                          Nettonal Rzscarch Council.-
                          (.,a I;qo r k
                                     2of r4it.,I-i Addict Ion "esear,h Center, Aanua I
                               geportv 22-23 January 19S4.  C:ontal@-is r-c-port on
                               the addictio.-I ltobillti4.,t of Oallfic-morp.@t-,ic
                                              -nd d 2-r4-Dir.,.-tt%        yr.-o r ph I n a n
                                ixturcs;     a                 YI    y
                               .. d 't
                                      and d
                               Y7,i I c r a cl IEthyl 2,2-Dilp;lienyt-4-Di7rcthylarilno-
                               butyra@c;
                                          2                             and d
                               all,/Inormcrphine; aid
                                                                Inc
                            b  Ar-tdiction Liabit "-y of 1,@arcot      C@e-. f 0 bz
                           (c)                     f y c f    r  a       y -r -:@'i v --'r @D x Y
      9                         i@.a r pn o n c2 Cc t c@ b,-, rZ')0
                                                      H.-, r r
                                                      Director o7' 2--scarch
                A t a   c ns

